BNP Paribas Issuance (P1IGD5) Noticias

Triggered

.......then the 2nd City, SCTV, Schmenge Bros. A Toronto production, eh.

So.....about these warrants....

Is there counter-play against the impending dilution of the GSE commons?

Hard to believe that Mr. Ackman is publicly advocating for the Government exercising the warrants - a position grossly against his own economic interests. I've specu

For Feb cc, I'm more interested in the forward expectations and Q&A than anything. Financials will be better, but don't think anything material. We'll finally surpass $20M rev in a quarter. If we don't,  style="font-size: 1em"Adderall is taking a hit from a market share standpoint.

CMPS
https://investorshub.advfn.com/uimage/uploads/2025/1/5/jsjjcIMG_4468.gif

You're welcome! BTW: Top up or top down? (I mean a convertible 😁)

The best degenerates state their Freedom of Speech here. Speaking of "X" account-I should participate more on it. I have a very boring life...

What clip ?? Mind sharing ?? 

It's not a handout from shitface himself, it's always our tax dollars and other peoples money. I know you know that, but the wormbrained like dirtberg need to be spoon feed.

Seriously I feel the conversions are done with. I think Friday signalled that. But I’m probably wrong. Or maybe I’m right. The market will tell us. Good luck

BREAKING: Senator Adam Schiff just ripped to shreds Kash Patel in a way I didn’t think was possible. Retweet to make sure every American sees this.

https://x.com/DemocraticWins/status/1875967340707488122

Not really, "IMHO". This is what you wrote: "I am not so sure and the question I have is, which position will the EMA take? A position similar to Doc and Investor (conventional)..." Why would the EMA take the uneducated position of "Doc" and "investor" instead of the highly educated, informed, and

MNMD
Mind Medicine (MindMed), Inc. operates as clinical stage biopharmaceutical company, which engages in developing novel product candidates to treat brain health disorders. The company was founded by Stephen L. Hurst, Scott M. Freeman, Leonard Latchman and Jamon Alexander Rahn on July 26, 2

Bar graph = monolith from movie '2001'. Dberg no touch, no learn. Comes to board/waterhole, get's clubbed mercilessly. The End.

4 part series...yikes what did I get into.

Hopium is a downer ….hocaine is an upper lol I am gonna hocaine this goes through the roof. But that’s me lmao

Thanks for the confession. That seems to be your OneMessageOnly-LIVES.

CBB...when Amarin needed cash for their R-It study, they borrowed the cash using their Vascepa patent as collateral for the loan...Amarin has paid off their debt and now has cash sitting idly... they could borrow more in order to fund an Lr Et EPA study....i.e. once the patent for this EPA med is g

Here is part of an ongoing discussion I've had with ChatGPT regarding the use of AIM with leveraged ETFs. Previous chats have focused on suitability and selection of specific leveraged ETFs that have sufficient volatility to work well with AIM. I have even used ChatGPT to write C++ code to manage an

NRXP at the Mar-A-Lago Club

HOPE Therapeutics, Inc., an NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Subsidiary, Will Host an Investor Workshop for Qualified Institutional Investors at the Mar-A-Lago Club During the Week of January 6, 2025

Jan 03, 2025,
https://www.pr

NRXP at the Mar-A-Lago Club

HOPE Therapeutics, Inc., an NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Subsidiary, Will Host an Investor Workshop for Qualified Institutional Investors at the Mar-A-Lago Club During the Week of January 6, 2025

Jan 03, 2025,
https://www.pr

X.....

lol! He's a good sleeper!!

NRXP at the Mar-A-Lago Club

HOPE Therapeutics, Inc., an NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Subsidiary, Will Host an Investor Workshop for Qualified Institutional Investors at the Mar-A-Lago Club During the Week of January 6, 2025

Jan 03, 2025,
https://ww

Yankee, the circus clowns will be out in full force trying to attack ELTP prior to the 3rd quarter report.
They know what is coming and it is not good news for them, Elite Rising!!!
Potential influences to Elite's 3rd quarter performance and report/conference call that will be probably

IXHL
Incannex Healthcare, Inc. is a biotech company, which engages in developing cannabinoid and psychedelic compound medicines. It focuses on the research and development for medicinal cannabis pharmaceutical products and psychedelic medicine therapies for treatment of a range of indications